175 related articles for article (PubMed ID: 7804514)
1. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
De Lima MD; Kohlmann NE; Neves FA; Zanella MT; Ribeiro AB; Kohlmann O
Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
[TBL] [Abstract][Full Text] [Related]
2. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
Sanjuliani AF; Fagundes VG; Francischetti EA
Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
[TBL] [Abstract][Full Text] [Related]
3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
4. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of enalapril in the treatment of essential hypertension.
Oksa A; Stefíková K; Fedelesová V; Baculáková V; Spustová V; Dzúrik R
Cor Vasa; 1992; 34(4):329-41. PubMed ID: 1308725
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
Amodeo C; Barros LM; Batlouni M; Sousa JE
Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
[TBL] [Abstract][Full Text] [Related]
7. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
8. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
9. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
Spence JD; Huff M; Barnett PA
Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
[TBL] [Abstract][Full Text] [Related]
11. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
12. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
[TBL] [Abstract][Full Text] [Related]
13. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
[TBL] [Abstract][Full Text] [Related]
14. Moderate sodium restriction and various diuretics in the treatment of hypertension.
Ram CV; Garrett BN; Kaplan NM
Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
[TBL] [Abstract][Full Text] [Related]
15. [Captopril and hydrochlorothiazide combined in the treatment of mild-to-moderate hypertension. Evaluation of sugar and lipid metabolism in a long-term study].
Malacco E; Magenta M; Noia E; Renesto E; Sartini C; Botta GF
Minerva Med; 1989 Oct; 80(10):1115-8. PubMed ID: 2682377
[TBL] [Abstract][Full Text] [Related]
16. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
Haenni A; Lithell H
J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
[TBL] [Abstract][Full Text] [Related]
17. Urapidil in hypercholesterolemic hypertensive patients.
Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
[TBL] [Abstract][Full Text] [Related]
18. [Comparative effects of captopril and chlorthalidone on glucose tolerance and insulin levels essential hypertensives].
Zanella MT; Baptista M; Costa CH; Kohlmann NE; Kohlmann Júnior O; Ribeiro AB
Arq Bras Cardiol; 1996 Jul; 67(1):47-52. PubMed ID: 9035467
[TBL] [Abstract][Full Text] [Related]
19. [Celiprolol improves glucose metabolism in essential hypertension].
Oksa A; Fedelesová V; Spustová V; Dzúrik R
Vnitr Lek; 1998 Feb; 44(2):63-7. PubMed ID: 9820078
[TBL] [Abstract][Full Text] [Related]
20. [Fosinorm in the treatment of essential hypertension with a metabolic syndrome].
Kobalava ZhD; Kotovskaia IuV; Moryleva ON; Drozdov VN; Ivleva AIa; Moiseev VS
Ter Arkh; 1997; 69(8):10-3. PubMed ID: 9381382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]